Comparative safety and efficacy of anti-PD-1 monotherapy, chemotherapy alone, and their combination therapy in advanced nasopharyngeal carcinoma: findings from recent advances in landmark trials
Jia‐Wei Lv(Sun Yat-sen University), Yu‐Pei Chen(Sun Yat-sen University), Zixian Wang(Sun Yat-sen University), Linna Luo(Sichuan University), Junyan Li(Sun Yat-sen University)
Cited by 82
Related Papers
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma
|Cell Research|2020|483
Long Noncoding RNA FAM225A Promotes Nasopharyngeal Carcinoma Tumorigenesis and Metastasis by Acting as ceRNA to Sponge miR-590-3p/miR-1275 and Upregulate ITGB3
|Cancer Research|2019|423
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline
|Journal of Clinical Oncology|2021|393
Long noncoding RNA AGPG regulates PFKFB3-mediated tumor glycolytic reprogramming
|Nature Communications|2020|258